Ren X, Chou Y, Wang Y, et al. - Researchers conducted this randomized open-label study to compare the effectiveness of intense pulsed light (IPL) and near‐infrared light (NIL) treatments in alleviating symptoms and signs of dry eye disease (DED). From January 2019 to October 2019, patients diagnosed with DED at the Peking University Third Hospital Eye Center were randomized to undergo either NIL therapy combined with meibomian gland expression (MGX; NIL Group) or IPL combined with MGX (IPL Group). In total, 260 eyes of 130 patients (mean age, 49.68 ± 18.01 years) were involved. Both IPL and NIL treatments were effective in treating DED, but IPL provided more symptom improvement, especially in patients with severe MG dropout. NIL has the potential to be a novel therapeutic option for the treatment of DED.